arXiv:2607.02944v1 Announce Type: cross Abstract: We propose PRECEDE, a precedent-guided co-scientist for side-effect-aware drug redesign that revises a parent compound to mitigate a specified side effect while preserving therapeutic function. Rather than isolated molecular generation, PRECEDE frames redesign as evidence-grounded reasoning over drug--side-effect associations, biomedical knowledge graphs, and precedents of safety-driven optimization, coordinated by an LLM orchestrator with explicit policies and human-review checkpoints. We position PRECEDE as a human-supervised AI-for-science w
The convergence of advanced large language models, sophisticated biomedical knowledge graphs, and the increasing demand for safer and more effective drug development makes drug redesign through AI a timely and critical area.
This development signals a significant advancement in AI's capability to operate as a 'co-scientist,' directly impacting the efficiency and efficacy of drug discovery and patient safety, potentially accelerating preclinical stages.
Drug redesign moves from purely experimental or human-intuition-driven processes to an evidence-grounded, AI-orchestrated approach that systematically mitigates side effects while preserving therapeutic function.
- · Biopharmaceutical companies
- · Patients with chronic diseases
- · AI-in-science platforms
- · Drug discovery & development sector
- · Traditional drug discovery models
- · Companies slow to adopt AI in R&D
Reduced drug development timelines and costs due to more efficient in silico redesign and pre-screening for side effects.
An increase in the number of successful drug candidates reaching clinical trials, leading to a broader therapeutic landscape.
The establishment of AI co-scientists as a standard component of pharmaceutical R&D, potentially democratizing access to complex drug design capabilities.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at arXiv cs.AI